author-photo

Cor Lamers

Erasmus University Medical Center

10

Papers

1477

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells

2013 Cytotherapy
Show All
- Source
- Cite
- Save
Citations (6)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

2013 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (445)
Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program.

2012 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (17)
Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells

2011 Blood
Show All
- Source
- Cite
- Save
Citations (254)
JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcome

2011 Cytotherapy
Show All
- Source
- Cite
- Save
Citations (3)
Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.

2006 Cytotherapy
Show All
- Source
- Cite
- Save
Citations (33)
Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (687)